LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...

Liquid biopsy is a revolutionary molecular diagnostic tool that allows scientists to detect genetic abnormalities or monitor disease progression non-invasively. However, clinicians encounter several ...

This eBook delves into the science behind first-void urine, exploring its composition, collection methods, and the latest ...

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.

In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...

The firm presented early data for a blood-based approach to screen prostate cancer patients for PSMA, which it believes has ...

In their liquid biopsy diagnostic platform ... The specialists introduce human cells into ultra-fine channels on microfluidic ...

"Although our patient cohort was small, it lays the groundwork for development of a type of 'non-invasive liquid biopsy' that ...

Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

Projects should be practice changing and must be focused on liquid biopsy for one or more of the following purposes for human primary brain tumors: Screening or diagnosis Detection of minimal ...

Discover how ctDNA offers a non-invasive approach to diagnosing and monitoring multiple myeloma, improving risk ...